Yusuke Nakamura to Monitoring, Immunologic
This is a "connection" page, showing publications Yusuke Nakamura has written about Monitoring, Immunologic.
Connection Strength
0.140
-
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med. 2012 Jul 09; 10:141.
Score: 0.109
-
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med. 2014 Mar 10; 12:63.
Score: 0.031